• Rite Aid has faced the might of Amazon and the likes of online pharmacies and convenient stores and shed over 90% of its value.
• However, the company's refocus has me optimistic that their turnaround efforts will bear fruit in the near term and the company will regain profitability in the tail end of 2019.
• From the most conservative to out-lavish fair value projections, I believe the company is undervalued by 35% to 250%, pending any changes in their turnaround strategy.
• I believe the company's turnaround is worth the time and investment.

There's little doubt that online delivery and shopping has crushed a large portion of brick-and-mortar retail and Rite Aid (RAD) is among those affected. The company, which once stood as a hallmark of brick-and-mortar giants with their drug stores and convenient stores nationwide, is now a dwindling resemblance of its past.

In recent years, as consumer spending in the area shifted online, the company found itself in a sticky spot where they lost large portions of their revenues to online giants like Amazon (AMZN) and others, but they do have some legacy business advantages where they can use their name recognition among the older generations and their eCommerce and cash reward efforts to get in some of the younger generations and boost their offerings.